• SENSEX 81,087.69
    -97.89 (--0.12%)
  • BANKNIFTY 55,617.60
    -344.35 (--0.62%)
  • Tata Motors
    647.20 542.55(%)
  • Axis Bank
    1,060.20 934.00(%)
  • Vimta Labs
    677.30 235.00(%)
  • GE Vernova T&D
    2,871.15 2,871.15(%)
  • Netweb Technol.
    2,299.15 3,060.00(%)
  • Suzlon Energy
    66.80 86.04(%)
  • Kaynes Tech
    6,483.00 7,824.95(%)
  • M & M
    3,117.25 2,360.45(%)
  • PNB Housing
    803.30 746.10(%)
  • Waaree Energies
    3,163.55 3,740.75(%)
  • HDFC Bank
    2,010.00 1,593.20(%)
  • Jayaswal Neco
    48.32 26.06(%)
  • Skipper
    548.00 665.00(%)
  • Shree Refrigerat
    177.70 177.70(%)
  • Timex Group
    244.75 289.90(%)
  • Hind. Unilever
    2,728.10 3,034.50(%)
  • TCS
    3,000.00 3,000.00(%)
  • Ceinsys Tech
    1,750.85 538.20(%)
  • Swiggy
    386.25 297.00(%)
  • KIOCL
    374.20 461.35(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Aarti Pharmalabs Ltd Pharmaceuticals - Indian - Bulk Drugs & Formln

  • Indian Private
  • BSE Code : 75909.0
  • ISIN : INE0LRU01027
864.00 -47 (-5.18%)
  • As on 02 Aug 2025 (EOD)

  • Today’s Low

    857.40

  • Today’s High

    918.35

  • Open

    911.20

  • Perv Close

    911.20

  • 52W Low

    557.05

  • 52W High

    971.00

Key Indicators

  • P/E(TTM)

    30.49

  • Mar.Cap (₹Cr.)

    7,830.83

  • Div & Yield %

    0.58

  • Book Value(₹)

    203.44

  • Debt-Equity Ratio

    -5.18

  • AGM Date

    01-Aug-2025

  • EPS

    28.39

  • P/E Ratio

    30.49

Financials Ratios

  • Debt-Equity Ratio

    0.15

  • Mar.Cap (₹Cr.)

    7,830.83

  • RONW (%)

    13.08

  • ROCE (%)

    16.60

Score Board

  • Equity (₹ in Cr.)

    45.32

  • BV (₹)

    203.40

  • Sales( ₹ in Cr.)

    1,771.35

  • NP (in Cr.)

    257.35

  • NP Var(%)

    28.0

  • Div%

    100.0

  • CPS (₹)

    37.10

  • EPS (₹)

    28.40

  • Traded Value (₹ in Lakhs)

    7,845.79

  • 52 Week High

    971.00

  • 52 Week Low

    557.05

  • Price BSE

    866.0

  • Price NSE

    864.00

  • Market Capital( in Cr.)

    7,845.79

  • P/C Ratio

    23.30

  • P/E Ratio

    30.50

  • Price Vs.BV

    28.40

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar
INCOME :            
Sales Turnover 1,502.13 1,511.25 941.02 0.00 0.00 -
Excise Duty 0.00 0.00 0.00 0.00 0.00 -
Net Sales 1,502.13 1,511.25 941.02 0.00 0.00 -
Other Income 11.01 1.28 2.51 0.00 0.00 -
Stock Adjustments 23.36 91.22 32.54 0.00 0.00 -
Total Income 1,536.50 1,603.75 976.07 0.00 0.00 -
EXPENDITURE :            
Raw Materials 775.33 909.15 484.20 0.00 0.00 -
Power and Fuel Cost 82.92 74.22 43.43 0.00 0.00 -
Employee Cost 120.15 113.92 79.98 0.00 0.00 -
Other Manufacturing Expenses 100.94 91.11 164.69 0.00 0.00 -
Selling and Administration Expenses 76.34 82.93 21.46 0.00 0.02 -
Miscellaneous Expenses 23.65 22.80 0.01 0.00 0.00 -
Employee Benefit Expenses 120.15 113.92 79.98 0.00 0.00 -
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 -
Total Expenses 1,179.33 1,294.14 793.78 0.00 0.02 -
Operating Profit 357.16 309.62 182.30 0.00 -0.02 -
Interest 16.63 20.49 11.34 0.00 0.00 -
Gross Profit 340.53 289.13 170.96 0.00 -0.02 -
Depreciation 66.01 55.77 37.23 0.00 0.00 -
Profit Before Tax 274.52 233.36 133.73 0.00 -0.02 -
Current Tax 46.06 52.13 22.50 0.00 0.00 -
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 -
Deferred Tax 27.82 9.50 4.50 0.00 0.00 -
Reported Net Profit 200.65 171.73 106.73 0.00 -0.02 -
Extraordinary Items 0.00 0.00 0.03 0.00 0.00 -
Adjusted Net Profit 200.65 171.73 106.70 0.00 -0.02 -
Adjustment below Net Profit 0.00 0.00 599.24 0.00 0.00 -
P & L Balance brought forward 859.55 705.95 -0.02 -0.02 0.00 -
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 -
Appropriations 18.13 18.13 0.00 0.00 0.00 -
P & L Balance carried down 1,042.07 859.55 705.95 -0.02 -0.02 -
Dividend 18.13 18.13 0.00 0.00 0.00 -
Preference Dividend 0.00 0.00 0.00 0.00 0.00 -
Equity Dividend (%) 60.00 40.00 0.00 0.00 0.00 -
Dividend Per Share(Rs) 3.00 2.00 0.00 0.00 0.00 -
Earnings Per Share-Unit Curr 22.14 18.95 4,269.05 -0.18 -0.75 -
Earnings Per Share(Adj)-Unit Curr 22.14 18.95 - - - -
Book Value 178.92 158.74 49,558.52 9.07 9.25 -
Book Value(Adj)-Unit Curr 178.92 158.74 - - - -

Shareholding Pattern

  • Promoter Group

    43.72%

  • Public Share Holding

    56.28%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 155,737 155,737.00 155,737 155,737
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 155,737 0.17 155,737 1
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 5,927,275 6.54 5,927,275 8
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 25,499,028 28.13 25,499,028 30
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 8,045,360 8.88 8,045,360 9
Others 0 0.00 0 0
Sub Total 39,471,663 43.55 39,471,663 47
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 8,864 0.01 8,864 1
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 1 0.00 1 1
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 6,661,276 7.35 6,661,276 111
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 5,462,835 6.03 5,462,835 2
Mutual Funds / UTI 816,109 0.90 816,109 9
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 786,006 0.87 786,006 9
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 13,735,091 15.15 13,735,091 133
2] Non Institution
Bodies Corporate 2,679,546 2.96 2,679,546 1,103
Clearing Members 1,051 0.00 1,051 8
Directors of their Relatives 9,103 0.01 9,103 2
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 1,425,539 1.57 1,425,539 4,635
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 978,222 1.08 978,222 2,685
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 10,768,603 11.88 10,768,603 72
Individuals holding nominal share capital up to Rs. 1 lakh 20,439,523 22.55 20,439,523 178,214
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 14,349 0.02 14,349 4
Others 312,752 0.35 312,752 3
Sub Total 37,272,133 41.12 37,272,133 186,858
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 90,634,624 100.00 90,634,624 187,039

Company Background

Aarti Pharmalabs LtdPharmaceuticals - Indian - Bulk Drugs & Formln

  • Aarti Pharmalabs Ltd
  • BSE Code : 75909.0
  • ISIN : INE0LRU01027

  • Incorporation Year

    2019

  • Registered Office

    Plot No 22/C/1 & 22/C/2
    1st Phase GIDC Vapi, Valsad,
    Gujarat-396195

  • Telephone

    91-22-6797 6666

  • FAX

    91-22-2565 3234

  • Chairman

    C V Gogri

  • Managing Director

    Hetal Gogri Gala

  • Company Secretary

    Jeevan Mondkar

  • Auditor

    Gokhale & Sathe

  • Face Value

    5

  • Listing

    NSE

  • Registrar

    MUFG Intime India Pvt Ltd
    C-101 247 Park,
    L B S Marg,Vikhroli West
    Mumbai - Mumbai-400083

Aarti Pharmalabs Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Aarti Pharma 865.65 1,513.14 1,502.13 30.49 16.40
Abbott India 33,676.00 6,684.73 6,409.15 50.59 44.95
Astrazeneca Phar 8,893.15 1,756.92 1,716.29 192.08 32.94
P & G Health Ltd 6,199.70 1,166.89 1,151.26 40.97 39.76
Glaxosmi. Pharma 2,933.90 3,866.05 3,723.49 52.76 58.72
Cipla 1,501.20 20,029.57 19,044.85 22.44 21.40
Amrutanjan Healt 676.35 437.58 421.23 38.47 20.84
Guj. Themis Bio. 371.85 174.19 169.82 90.92 44.82
Fermenta Biotec. 362.00 442.21 430.53 15.76 17.61
Bliss GVS Pharma 173.70 703.42 667.20 25.96 9.16
Ambalal Sarabhai 32.97 19.33 4.04 30.53 2.10